Clinical trial
Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
NCT03602833 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
- Lead sponsor
- Royal Marsden NHS Foundation Trust
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 5, 2018
- Completion date
- June 30, 2023
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
soft-tissue sarcoma